- Medicaid work rules: What’s in, what’s out and where hospitals stand
- Med-Metrix to acquire Vitalware from Health Catalyst
- 850 Virtua nurses issue strike notice
- What leaders need to know about the breakthrough pancreatic cancer pill
- SSM Health receives $10M from MLS team owner
- Hospital CEO: BCBS Alabama must pay us by June 25, or closure begins
- Deaconess hospital taps new chief administrative officer
- 61% of high-risk Minnesota Medicaid providers face disenrollment amid $2B threat
- 3 dental technologies earning FDA clearance
- Novant Health pilots AI-powered virtual assistant
- Fraud crackdown heats up: 9 physicians in 60 days
- Optum to close another Indiana physician practice
- Closures, bankruptcies and consent orders: 5 ASC controversies from the last year
- 3 years and up to 15,000 fake nursing degrees later, Operation Nightingale reaches trial
- The No Surprises Act’s game of ‘hot potato’
- New Maryland law expands assignment of benefit protections for dentists, patients
- Insurers overturn 80% of denied IBD therapy claims on appeal — but only 4% are ever challenged
- Rhode Island House passes bill expanding reimbursement options for hygienists: 5 notes
- Dental assistants’ pay jumped the most in these 10 states
- 4 charged in $30M behavioral health fraud case
- Medicaid termination notices disrupt South Florida behavioral healthcare
- Cooper University Health Care plans $300M ASC, outpatient campus
- “Harmonization: We’ll Have Lots to Talk About”
- HUD overhauls $4B homelessness program
- Heartland Dental added 8 practices in May
- What the USAP-FTC settlement means for ASC anesthesia contracting
- 15 spine surgeons to know
- Ascension inks $3.9B AmSurg deal, adds 300 ASCs after FTC requires 7 divestitures
- PDS Health marks $1M in tuition assistance for dental assisting students
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- 5 highest-paying cities for dentists in 2026
- Veteran ASC recruiter merges ASC, hospital nursing leadership practices
- ‘The need has not magically decreased’: John Muir temporarily closes 21 psych beds amid California’s staffing order
- Poll Finds Broad Support For Stricter Regulations On Ultra-Processed Foods
- It's unanimous: SCOTUS agrees with Hikma in 'skinny label' case vs. Amarin
- DSOs, dental schools and companies secure $270M in funding boons
- Remarks at the Investor Advisory Committee Meeting
- Nearly 1 in 5 Young People Turn to AI Chatbots for Mental Health Advice
- Georgetown study: 2M children have dropped out of Medicaid, CHIP since January 2025
- ScionHealth sends 8 community hospitals to Lifepoint Health
- ADC Therapeutics' shares plummet after patient deaths in trial of Zynlonta
- As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
- Older LGBTQ+ Adults Fear Less Support As They Age, Poll Shows
- Night Owls Are More Prone To Anxiety, Loneliness
- Home-Delivered Medical Meals Reduce ER Visits, Save Money
- Axsome fends off generic competition to narcolepsy med Sunosi until 2040
- Menopause Hormone Therapy Use Drops Sharply Across United States
- Michigan Found A Way To Reduce School Vaccine Waivers — Until It Backfired
- Listen to the Latest ‘KFF Health News Minute’
- RFK Jr. Seeks To Peek at Americans’ Medical Records for Clues on Autism and Vaccines
- Louisiana’s Reporting Law Chills Immigrant Medicaid Applications
- Thyme Care expands cancer survivorship program to provide longitudinal support
- Medline earns FDA warning letter ire for repeated toxic bacteria problems
- House committee advances federal dental workforce bill
- Pearl, Seattle Study Club partner on dental AI education
- Michigan psychiatric hospitals cut patient injuries 58%
- 28 behavioral health executive moves to know
- Carilion behavioral health role cuts staff injuries 70%-90%
- Trump’s Medicaid Work Rules Force States To Scrap Plans and Rework Systems
- UnitedHealthcare used false behavioral health diagnoses to defraud Massachusetts Medicaid, lawsuit alleges
- US overdose deaths drop 24.4%, largest decline on record: 6 things to know
- Adult drug use disorder rates by state
- Commonwealth Fund: 21% of adults experienced a coverage denial in the past year
- Millions on Medicaid May Soon Have To Prove They’re Working To Keep Coverage
- Anomaly Insights launches AI solution for managed care executives
- Lilly, Boehringer to slash at least $1B each from planned investments in Germany
- Presbyterian Healthcare Services to discontinue MA plans in 2027, cut 150 jobs
- Just 90 Minutes Of Strength Training A Week Linked To Longer Life
- AHA lays out blueprint to improve affordability, care access and quality
- Amid Miplyffa launch, Zevra CEO aims to foster EU-style Niemann-Pick market in US
- Chemo-Free Drug, Tecvayli, Shows Major Survival, Remission Gains In Relapsed Multiple Myeloma
- Urine Test Can Detect Autism, Study Says
- High-Puff Vapes Become More Toxic Over Time, Study Says
- With Cencora pact, Gilead looks to grow CAR-T treatment center network
- The watchdog overseeing the integrity of HHS programs
- Coffee, racetracks, beaches and more coffee—inside the ASCO 2026 exhibit floor
- GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30%
- Telehealth Booms As Demand For GLP-1s Surges and Questions Mount About Safety, Oversight
- At a Tennessee Hospital, a Nurse Stole Fentanyl and AI Missed It, State Records Say
- Michigan Found a Way To Reduce School Vaccine Waivers. Until It Backfired.
- A patient-first shift in disease language and communication
- FDA issues untitled letter after finding ‘eye-catching graphics’ in promotional emails
- Neurotech launches new YouTube channel to spotlight patients’ stories for rare eye disorder
- As Akeso takes center stage at ASCO, China biotech industry cements its coming of age
- Base Case: Remarks at the IC3 Blockchain Camp
- Microsoft, Mayo Clinic plan to build frontier AI model for healthcare
- OIG: Feds may have overpaid MA plans by millions due to unsupported stroke diagnoses
- Department of Labor's proposed foreign worker wage increases are more tough news for healthcare staffing
- Trump Signs Order Calling For Fewer Childhood Vaccines
- Industry groups say final Medicaid work requirements rule imposes onerous documentation burden
- Ascension closes its $3.9B AmSurg purchase following FTC's all-clear
- Simple Blood Test May Help Detect And Stage Alzheimer's Disease
- Festering Infections to Untreated Cancer: ICE Detainees Describe Medical Neglect Across US
- A look at wearable adoption trends and who's using 'smart' devices: Rock Health
- Eli Lilly's ultimatum to hospitals: Send 340B claims data by June 8 or lose discounts
- Eli Lilly's ultimatum to hospitals: Send 340B claims data by June 8 or lose discounts
- Marilyn Monroe and Amy Schumer profiled in endometriosis awareness push
- Merck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances
- Joint Commission launches voluntary AI certification program for healthcare organizations
- Gilead's Livdelzi scores in rare liver disease trial, portending use in broader patient population
- Smartphone App Helps Those With Advanced Cancer Maintain Quality Of Life
- Asthma Drug, Tezspire, Cuts Need For Steroid Pills While Keeping Attacks In Check
- Childhood Flu Shots Prevent Millions of Cases, Study Finds
- Sanofi taps Snowflake for AI field agent help
- Merck weighs use of COVID antiviral Lagevrio as Ebola outbreak worsens
- ADHD drug delivery specialist Cingulate hit with manufacturing-related FDA rejection
- Amid Ebola, Hantavirus Outbreaks, Democrats Decry Trump's Health Cuts
- TikTok Videos Fuel Illicit Vaping Culture Among Underage Youth
- Focused on Work, Needed at Home: A Federal Caregiving Policy Might Help
- Eisai whips up Alzheimer’s dietary guidance to expand nutrition program beyond cancer
- AI-powered medical imaging startup Subtle Medical picks up $33M and taps new CEO
- Northwell's firearm injury risk screener now widely available within Epic
- Commission Statement on the Passing of Former General Counsel David Becker
- CMS outlines national framework to support rollout of Medicaid work requirements
- Your Surprise Medical Bill May Be Gone — But Your Premiums Could Still Spike
- Athenahealth rolls out over 80 new, expanded AI RCM features in ‘roadmap’ on athenaOne platform
- Contraline and its male birth control candidate rally $92.5M amid push into 'massive white space' of men's health
- Short-Term Fasting Could Boost Chemo Response in Ovarian Cancer, Study Suggests
- Wolters Kluwer Health survey examines AI use and concerns among clinicians, patients in 2026
- Workout Habits May Protect Against Inherited Heart Problems
- Childhood Lying Is Normal and Rarely Signals Behavioral Concerns, Study Says
- Perfectionism Among College Students Reaches Record High, Fueling Anxiety
- After Her Bout of Amnesia, A $59,000 Billing Dispute Wouldn't Go Away
- Weed Linked To Higher Testosterone Levels In Young Men
- Amid Ebola, Hantavirus Outbreaks, Democrats Decry Trump’s Health Cuts
- Telehealth Booms as Demand for GLP-1s Surges and Questions Mount About Safety, Oversight
- Rising Stars: WPP’s Meghan O’Hora on the ‘complex puzzle’ of oncology drug marketing
- Contraception For Teens: Let's Talk About It
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- CAT on a Hot Tin Roof
- Remarks at the Stanford Rock Center for Corporate Governance
- Statement on Novel Exchange-Traded Funds (ETFs)
- ASCO: Roche, head held high, details oral SERD's first-line flop in breast cancer
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
Michigan healthcare freedom community forum
Many long COVID sufferers feel that their real problems were ignored while public health went ape over COVID counts, transmission rates, and enforcing masks and vaccines.
This New York Times report of serotonin-implicated research may finally help advance solutions for memory loss and other real problems of COVID.
Scientists Offer a New Explanation for Long Covid
Oct. 16, 2023
The News
A team of scientists is proposing a new explanation for some cases of long Covid, based on their findings that serotonin levels were lower in people with the complex condition.
In their study, published on Monday in the journal Cell, researchers at the University of Pennsylvania suggest that serotonin reduction is triggered by remnants of the virus lingering in the gut. Depleted serotonin could especially explain memory problems and some neurological and cognitive symptoms of long Covid, they say.
Why It Matters: New ways to diagnose and treat long Covid.
This is one of several new studies documenting distinct biological changes in the bodies of people with long Covid — offering important discoveries for a condition that takes many forms and often does not register on standard diagnostic tools like X-rays.
The research could point the way toward possible treatments, including medications that boost serotonin. And the authors said the biological pathway that their research outlines could unite many of the major theories of what causes long Covid: lingering remnants of the virus, inflammation, increased blood clotting and dysfunction of the autonomic nervous system.
“All these different hypotheses might be connected through the serotonin pathway,” said Christoph Thaiss, a lead author of the study and an assistant professor of microbiology at the Perelman School of Medicine at the University of Pennsylvania.
“Second of all, even if not everybody experiences difficulties in the serotonin pathway, at least a subset might respond to therapies that activate this pathway,” he said.
“This is an excellent study that identifies lower levels of circulating serotonin as a mechanism for long Covid,” said Akiko Iwasaki, an immunologist at Yale University. Her team and colleagues at the Icahn School of Medicine at Mount Sinai recently published a study that identified other biological changes linked to some cases of long Covid, including levels of the hormone cortisol. These studies could point to specific subtypes of long Covid or different biological indicators at different points in the condition.
The Back Story: A series of disruptions set off by bits of virus in the gut.
Researchers analyzed the blood of 58 patients who had been experiencing long Covid for between three months and 22 months since their infection. Those results were compared to blood analysis of 30 people with no post-Covid symptoms and 60 patients who were in the early, acute stage of coronavirus infection.
Maayan Levy, a lead author and assistant professor of microbiology at the Perelman School of Medicine, said levels of serotonin and other metabolites were altered right after a coronavirus infection, something that also happens immediately after other viral infections.
But in people with long Covid, serotonin was the only significant molecule that did not recover to pre-infection levels, she said.
The team analyzed stool samples from some of the long Covid patients and found that they contained remaining viral particles. Putting the findings in patients together with research on mice and miniature models of the human gut, where most serotonin is produced, the team identified a pathway that could underlie some cases of long Covid.
Here’s the idea: Viral remnants prompt the immune system to produce infection-fighting proteins called interferons. Interferons cause inflammation that reduces the body’s ability to absorb tryptophan, an amino acid that helps produce serotonin in the gut. Blood clots that can form after a coronavirus infection may impair the body’s ability to circulate serotonin.
Depleted serotonin disrupts the vagus nerve system, which transmits signals between the body and the brain, the researchers said. Serotonin plays a role in short-term memory, and the researchers proposed that depleted serotonin could lead to memory problems and other cognitive issues that many people with long Covid experience.
“They showed that one-two-three punch to the serotonin pathway then leads to vagal nerve dysfunction and memory impairment,” Dr. Iwasaki said.
There are caveats. The study was not large, so the findings need to be confirmed with other research. Participants in some other long Covid studies, in which some patients had milder symptoms, did not always show depleted serotonin, a result that Dr. Levy said might indicate that depletion happened only in people whose long Covid involves multiple serious symptoms.
What’s Next: A clinical trial of Prozac.
Scientists want to find biomarkers for long Covid — biological changes that can be measured to help diagnose the condition. Dr. Thaiss said the new study suggested three: the presence of viral remnants in stool, low serotonin and high levels of interferons.
Most experts believe that there will not be a single biomarker for the condition, but that several indicators will emerge and might vary, based on the type of symptoms and other factors.
There is tremendous need for effective ways to treat long Covid, and clinical trials of several treatments are underway. Dr. Levy and Dr. Thaiss said they would be starting a clinical trial to test fluoxetine, a selective serotonin reuptake inhibitor often marketed as Prozac, and possibly also tryptophan.
“If we supplement serotonin or prevent the degradation of serotonin, maybe we can restore some of the vagal signals and improve memory and cognition and so on,” Dr. Levy said.
https://www.nytimes.com/2023/10/16/health/long-covid-serotonin.html
Pam Belluck is a health and science writer whose honors include sharing a Pulitzer Prize and winning the Victor Cohn Prize for Excellence in Medical Science Reporting. She is the author of “Island Practice,” a book about an unusual doctor.
Ms. Belluck writes about a wide range of subjects, including the coronavirus pandemic, reproductive health, brain science, neurological disorders and mental health. Her work on Ebola with six colleagues won the 2015 Pulitzer Prize for international reporting and other awards. Her project about surgery for women traumatized by genital cutting won a Nellie Bly Award for Best Front Page Story and other honors. Ms. Belluck’s reporting on the devastating effects of Covid was honored with a New York Press Club Award and a Newswomen’s Club Front Page Award. She contributed, along with many colleagues, to the Times’s pandemic coverage, which earned the paper a 2021 Pulitzer for public service. Ms. Belluck, along with a photographer and translator, also won a New York Press Club award for reporting in Brazil on babies harmed by the Zika virus.Ms. Belluck has reported on Alzheimer’s from mountain villages in Colombia, a California prison and dementia centers in South Korea, and she has investigated the controversial Alzheimer’s drug Aduhelm. Her two-part series Mother’s Mind helped spur efforts to detect and treat maternal depression. She also covers lighter topics, including the discovery of the world’s oldest leather shoe (size 7, right foot, preserved for 5,500 years in sheep dung), and her piece on a lost cat navigating 200 miles home inspired a children’s book.
Her work has been chosen for The Best American Science Writing and The Best American Sports Writing. She won a Fulbright Scholarship and a Knight Journalism Fellowship and was selected to be a Ferris Professor of Journalism at Princeton University. She is frequently invited to speak about her work and has served on advisory boards related to science communication.
Her book, “Island Practice,” about a colorful and contrarian doctor whose patients have included Kennedys and a hermit in a vine igloo, is being considered for a TV series. In her spare time, Ms. Belluck is a jazz flutist.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















